Active Ingredient: BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Proprietary Name: BENZACLIN
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 5%;EQ 1% BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050756
Product Number: 001
Approval Date: Dec 21, 2000
Applicant Holder Full Name: BAUSCH HEALTH AMERICAS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information